Eloxx Pharmaceuticals, Inc. - Special Call Transcript
Welcome, everyone. I'm Asher Hodes from Covington & Burling. The next presenting company is Eloxx Pharmaceuticals from Waltham, Massachusetts. Eloxx is focused on orphan and rare diseases, platform technology, and pulmonary, renal and ophthalmic indications.
Presenting for Eloxx Pharmaceuticals is their Chairman and CEO, Robert Ward. There will be a breakout afterwards in public breakout room #2.
Thank you very much for joining me today for our first presentation to kick off 2020. During the course of my presentation today on Eloxx Pharmaceuticals, I'll be making forward-looking statements, and I'd ask that you refer to our most recent 10-K and other SEC filings.
2019 was a very exciting year with the completion of our first cohort in cystinosis. And today, I'll be sharing with you the top line results from that program as well as an update on our Phase II trial in cystic fibrosis and the promising activities that we see
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |